Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OpGen, Inc.

http://opgen.com/

Latest From OpGen, Inc.

Molecular Diagnostic Firms Curetis And OpGen Announce Merger

The combination of the molecular diagnostic companies is structured as an acquisition of Curetis by OpGen. The merged companies will be a based in the US.

Commercial M & A

Deals Shaping the Medical Industry, August 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced July 2017.

Deals BioPharmaceutical

Rapid Infectious Disease Testing Picks Up Speed

Recent regulatory events and dealmaking highlight an increase in the pace of innovation in rapid infectious disease testing.

Medical Device Innovation

Medtech Execs On The Move, June 2016

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Services
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
  • Other Names / Subsidiaries
    • AdvanDx, Inc.
    • AdvanDx A/S, Curetis N.V.
UsernamePublicRestriction

Register